Add to ORKG(page number not for citation purposes) Vol 11 No 4 Research article Markers of B-lymphocyte activation are elevated in patients with early rheumatoid arthritis and correlated with disease activity in the ESPOIR cohor
Rheumatoid arthritis is a chronic autoimmune disease occurring in ~1% of the world population. The m...
Background: The diagnosis of early rheumatoid arthritis (RA) is challenging. B-cell chemokine (CXCL1...
In the last years, a dramatic amount of research has been performedincreasing the knowledge about th...
International audienceINTRODUCTION: Little is known about systemic B-cell activation in early rheuma...
© The Author 2010. Published by Oxford University Press on behalf of the British Society for Rheumat...
CC This is an open access article distributed under the terms of the Creative Commons Attribution No...
The therapeutic benefit of depleting B cells in rheumatoid arthritis (RA) has refocused attention on...
Cytokine pattern in very early rheumatoid arthritis favours B-cell activation and surviva
Copyright © 2014 Serena Bugatti et al. This is an open access article distributed under the Creative...
International audienceOBJECTIVE: To identify a specific pattern of serum cytokines that correlates w...
Objectives A previously identified signal transduction and activator of transcription-3 (STAT3) targ...
B-lymphocyte activating factor in systemic lupus erythematosus and rheumatoid arthritis in relation ...
The precise mechanisms involved in the initiation and progression of rheumatoid arthritis (RA) are n...
Background: We have recently analyzed the profile of T-cell subtypes based on chemokine receptor exp...
Rheumatoid arthritis is an autoimmune disease in which various mediators of immune function play a v...
Rheumatoid arthritis is a chronic autoimmune disease occurring in ~1% of the world population. The m...
Background: The diagnosis of early rheumatoid arthritis (RA) is challenging. B-cell chemokine (CXCL1...
In the last years, a dramatic amount of research has been performedincreasing the knowledge about th...
International audienceINTRODUCTION: Little is known about systemic B-cell activation in early rheuma...
© The Author 2010. Published by Oxford University Press on behalf of the British Society for Rheumat...
CC This is an open access article distributed under the terms of the Creative Commons Attribution No...
The therapeutic benefit of depleting B cells in rheumatoid arthritis (RA) has refocused attention on...
Cytokine pattern in very early rheumatoid arthritis favours B-cell activation and surviva
Copyright © 2014 Serena Bugatti et al. This is an open access article distributed under the Creative...
International audienceOBJECTIVE: To identify a specific pattern of serum cytokines that correlates w...
Objectives A previously identified signal transduction and activator of transcription-3 (STAT3) targ...
B-lymphocyte activating factor in systemic lupus erythematosus and rheumatoid arthritis in relation ...
The precise mechanisms involved in the initiation and progression of rheumatoid arthritis (RA) are n...
Background: We have recently analyzed the profile of T-cell subtypes based on chemokine receptor exp...
Rheumatoid arthritis is an autoimmune disease in which various mediators of immune function play a v...
Rheumatoid arthritis is a chronic autoimmune disease occurring in ~1% of the world population. The m...
Background: The diagnosis of early rheumatoid arthritis (RA) is challenging. B-cell chemokine (CXCL1...
In the last years, a dramatic amount of research has been performedincreasing the knowledge about th...